Press release
CD Bioparticles Introduces Flow Cytometry Gold Nanoparticles for Enhanced Cellular Analysis
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is pleased to announce the launch of its new Flow Cytometry Gold Nanoparticles [https://www.cd-bioparticles.com/products/flow-cytometry-gold-nanoparticles-357.html] to support flow cytometry analysis by providing a robust and versatile tool for optimizing instrument settings and evaluating particle or organism populations in solution. These gold nanoparticles offer unparalleled precision and sensitivity for cellular analysis.
The Flow Cytometry Gold Nanoparticle is a gold nanoparticle that can be used for flow cytometry, a method of measuring and analyzing individual cells and particles in solution. Gold nanoparticles have unique optical, electronic and physical properties, including strong light scattering, high surface area-to-volume ratio and simple surface chemistry, and therefore offer significant advantages for flow cytometry. For flow cytometry, gold nanoparticles can be conjugated to specific biomolecules, such as antibodies or aptamers, to accurately detect and analyze specific targets in complex biological samples.
CD Bioparticles offers flow cytometry gold nanoparticles in a range of sizes from 70 nm to 400 nm. These particles exhibit strong light scattering and absorption in the visible and near-infrared range, enabling sensitive and specific detection in flow cytometry. Their surface can be functionalized with biomolecules such as antibodies or aptamers, allowing targeted binding to specific cells or molecules. In addition, these nanoparticles have excellent thermal, mechanical and chemical stability, low toxicity and good biocompatibility.
The flow cytometry gold nanoparticles from CD Bioparticles are versatile tools for a broad spectrum of biomedical research and bioassay development, with applications in diverse fields such as cancer diagnosis and therapy, infectious disease detection, vaccine development, neurological research, and environmental monitoring. These innovative nanoparticles will empower researchers to achieve greater accuracy and sensitivity in their flow cytometry experiments.
For example, the DiagNano Trademark Gold Nanoparticles Trial Kit (Cat. No. BG-LargeKit-FCM) is designed for research applications. It contains 1ml each of gold nanoparticles in four different sizes: 100nm, 200nm, 300nm, and 400nm. These specifically sized particles are ideal for optimizing the settings and performance of flow cytometer, allowing for the evaluation of other particles and organisms in samples.
Given the wide range of applications of nanoparticles in biological and medical fields, CD Bioparticles offers the most comprehensive portfolio of nanoparticles of different sizes and surface properties to meet research and industrial development needs. In addition, CD Bioparticles provides extensive products and services for immunoassays, bioseparations, medical imaging and diagnostics, as well as drug delivery and cancer therapy.
CD Bioparticles is dedicated to providing innovative nanoparticles to help scientists delve deeper into the intricacies of cellular biology and drive groundbreaking discoveries. To learn more about the new Flow Cytometry Gold Nanoparticles and other products at CD Bioparticles, please visit https://www.cd-bioparticles.com/products/flow-cytometry-gold-nanoparticles-357.html.
About CD Bioparticles
CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.
Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-introduces-flow-cytometry-gold-nanoparticles-for-enhanced-cellular-analysis]
State: New York
Country: United States
Website: https://www.cd-bioparticles.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD Bioparticles Introduces Flow Cytometry Gold Nanoparticles for Enhanced Cellular Analysis here
News-ID: 3755119 • Views: …
More Releases from ABNewswire
Myasthenia Gravis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myasthenia Gravis pipeline constitutes 20+ key companies continuously working towards developing 22+ Myasthenia Gravis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Myasthenia Gravis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
SLIM CD Introduces Next-Generation Transaction Controls and Compliance Features …
SLIM CD introduces new transaction controls, PCI compliance reporting, tokenization management, and API governance, offering merchants greater security and flexibility. These updates help businesses stay compliant with evolving industry requirements while improving payment processing efficiency. Key features include tiered authorization thresholds, enhanced user experience, and EMV device compliance tools, all available immediately to SLIM CD merchants.
Coral Springs, FL - October 7, 2025 - SLIM CD, Inc., a leading payments software…
Stargardt Disease Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Ev …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Stargardt Disease pipeline constitutes 20+ key companies continuously working towards developing 20+ Stargardt Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Stargardt Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
Spinal Cord Injury Market Positioned for Accelerated Development Through 2034, D …
The Key Spinal Cord Injury Companies in the market include - Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others.
DelveInsight's "Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Spinal Cord Injury, historical and forecasted epidemiology as well as the Spinal Cord Injury market trends in…
More Releases for Bioparticles
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported.
Flow cytometry is a convenient detection…
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research …
CD Bioparticles proudly announces the launch of its new Functional Agarose Particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its new Functional Agarose Particles [https://www.cd-bioparticles.com/products/functional-agarose-particles-1065.html] designed for a variety of applications in the field of bioconjugation, isolation, and purification of biomacromolecules. These particles are ideal for researchers working in areas such as protein purification, antibody production, and nucleic acid isolation.
CD…
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability.
The polystyrene family, a group of polymers derived from…
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications.
Low dispersion index polymers are polymeric compounds with low molecular…
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents.
CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such…
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings.
With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the…
